Harmony Biosciences’ Genetic Disorder Drug Fails to Meet Main Goal in Late-stage Trial



Harmony Biosciences said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its shares down more…
Reuters Health Information



Source link : https://www.medscape.com/s/viewarticle/harmony-biosciences-genetic-disorder-drug-fails-meet-main-2025a1000pju?src=rss

Author :

Publish date : 2025-09-24 12:33:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version